Status:
UNKNOWN
Understanding Balance Impairment in COPD
Lead Sponsor:
Teesside University
Conditions:
Chronic Obstructive Pulmonary Disease
Healthy Volunteers
Eligibility:
All Genders
55+ years
Brief Summary
This study is an observational study investigating the mechanisms of balance problems in people with COPD and how COPD impacts them living their daily lives. The main objectives of this study are: *...
Detailed Description
Chronic obstructive pulmonary disease (COPD) is a progressive condition that affects around 1.2million people in the UK. Breathlessness is the main symptom but people with COPD are also more likely to...
Eligibility Criteria
Inclusion
- COPD
- Have a spirometry confirmed diagnosis of COPD as per GOLD guidelines
- Stable COPD (six weeks clear of exacerbation)
- 55 years or over at the point of recruitment
- Able to communicate with good verbal English or use adaptive equipment to communicate
- Male or female Controls
- Free from a diagnosis of COPD (confirmed by spirometry)
- 55 years or over at the point of recruitment
- Able to communicate with good verbal English or use adaptive equipment to
- Communicate
- Male or female
Exclusion
- COPD
- Recent exacerbation of COPD (within the last six weeks)
- Under 55 years of age at the point of recruitment
- Any neurological or musculoskeletal diagnoses (e.g., strokes, Parkinson's disease or chronic pain that interferes with ability to safely complete the tests
- Unable to provide written informed consent
- Unable to speak English or no translation options available
- Diagnosed but not corrected visual, vestibular disturbance and peripheral neuropathy
- Vasovagal syncope
- Not independent living (e.g., living in a care home or prison) Controls
- Abnormal lung function (FEV1 and FVC equal to or greater than 80% and FEV1/FVC equal to greater than 70%)
- Under 55 years of age at the point of recruitment
- Any neurological or musculoskeletal impairment that would significantly affect balance impacting ability to safely complete the assessments
- Unable to provide written informed consent
- Unable to speak English or no translation options available
- Any uncorrected visual or somatosensory disturbance
- Vasovagal syncope
- Living in a care home or in prison
Key Trial Info
Start Date :
July 17 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05984498
Start Date
July 17 2023
End Date
May 1 2024
Last Update
August 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Teesside University
Middlesbrough, United Kingdom, TS1 3BX